Conditions: HIV Enteropathy Diarrhea With HIV
Keywords: HIV + HIV positive HIV associated diarrhea AIDS Diarrhea
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 250
Healthy volunteers: no

Brief summary:
This study is being conducted to evaluate the safety and tolerability of crofelemer 125 mg twice a day, taken orally, over 48 weeks of therapy in human immunodeficiency virus-positive (HIV+) subjects with diarrhea.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Crofelemer
Intervention descriptions: intervention 1: Crofelemer will be administered orally as 1 tablet(125 mg)BID for a total daily dose of 250mg crofelemer.

Protocol document: